LECT2水平与肺炎链球菌肺炎患儿发生坏死性肺炎的关系及临床意义

doi:10.3760/cma.j.issn.1007-1245.2024.20.009

摘要/Abstract

摘要：

目的　本研究旨在探讨白细胞衍生趋化因子2（LECT2）水平与肺炎链球菌肺炎患儿发生坏死性肺炎的关系及其临床意义，为肺炎链球菌肺炎的早期诊断和治疗提供参考。方法　回顾性分析西安高新医院2022年1月至2024年1月收治的104例肺炎链球菌肺炎患儿的临床资料。根据是否发生坏死性肺炎，将患儿分为坏死性肺炎组（49例）和非坏死性肺炎组（55例）。坏死性肺炎组中男26例，女23例，年龄（7.62±2.58）岁；非坏死性肺炎组中男27例，女28例，年龄（7.18±2.03）岁。比较两组患儿的LECT2水平、血常规［C反应蛋白（CRP）、乳酸脱氢酶（LDH）、降钙素原（PCT）］以及细胞因子［肿瘤坏死因子α（TNF-α）和γ干扰素（IFN-γ）］水平。分析LECT2水平与坏死性肺炎的关系及肺炎链球菌肺炎患儿发生坏死性肺炎的影响因素。建立坏死性肺炎预测模型，并分析其预测效能。采用χ²检验、t检验。结果　两组患儿的发热时间、住院时间、有无胸腔积液、是否胸膜增厚比较，差异均有统计学意义（均P<0.05）。坏死性肺炎组患儿LECT2、CRP、LDH和PCT水平分别为（28.36±4.46）mg/L、（91.47±7.48）mg/L、（462.27±61.44）U/L、（0.25±0.10）µg/L，非坏死性肺炎组分别为（26.07±5.17）mg/L、（77.65±7.59）mg/L、（346.85±48.93）U/L、（0.11±0.04）µg/L，差异均有统计学意义（t=2.404、9.332、10.649、9.564，均P<0.05）。LECT2、CRP、LDH和PCT均是肺炎链球菌感染患儿继发坏死性肺炎的影响因素（均P<0.05）。预测肺炎链球菌感染患儿发生坏死性肺炎的各指标中，LECT2曲线下面积为0.636，各指标联合检测曲线下面积为0.988，联合检测具有更高的诊断价值。结论　LECT2水平与肺炎链球菌肺炎患儿发生坏死性肺炎密切相关，其水平的升高可能增加患儿发展为坏死性肺炎的风险。因此，LECT2可作为预测肺炎链球菌肺炎患儿发展为坏死性肺炎的潜在生物标志物，有助于临床医生在早期阶段采取更有针对性的治疗措施，从而改善患儿预后。

关键词:

肺炎链球菌肺炎, 坏死性肺炎, 白细胞衍生趋化因子2, 早期诊断, 儿童

Abstract:

Objective　To explore the relationship between level of leukocyte derived chemokine 2 (LECT2) and occurrence of necrotizing pneumonia in children with Streptococcus pneumoniae pneumonia and its clinical significance, in order to provide a reference for early diagnosis and treatment of Streptococcus pneumoniae pneumonia. Methods　The clinical data of 104 children with Streptococcus pneumoniae pneumonia admitted to Xi'an Gaoxin Hospital from January 2022 to January 2024 were retrospectively analyzed. According to the occurrence of necrotizing pneumonia, the children were divided into a necrotizing pneumonia group (49 cases) and a non-necrotizing pneumonia group (55 cases). In the necrotizing pneumonia group, there were 26 boys and 23 girls, aged (7.62±2.58) years. In the non-necrotizing pneumonia group, there were 27 boys and 28 girls, aged (7.18±2.03) years. The levels of LECT2, blood routine [C-reactive protein (CRP), lactate dehydrogenase (LDH), and procalcitonin (PCT)], and cytokines [tumor necrosis factor α (TNF-α) and γ interferon (IFN-γ)] were compared between the two groups. The relationship between LECT2 level and necrotizing pneumonia was analyzed, and the influencing factors of necrotizing pneumonia in children with Streptococcus pneumoniae pneumonia were analyzed. The prediction model for necrotizing pneumonia was established and its prediction efficiency was analyzed. χ² test and t test were used. Results　There were statistically significant differences between the two groups in terms of the duration of fever, hospital stay, pleural effusion, and pleural thickening (all P<0.05). The levels of LECT2, CRP, LDH, and PCT in the necrotizing pneumonia group were (28.36±4.46) mg/L, (91.47±7.48) mg/L, (462.27±61.44) U/L, and (0.25±0.10) µg/L, and those in the non-necrotizing pneumonia group were (26.07±5.17) mg/L, (77.65±7.59) mg/L, (346.85±48.93) U/L, and (0.11±0.04) µg/L, with statistically significant differences (t=2.404, 9.332, 10.649, and 9.564, all P<0.05). LECT2, CRP, LDH, and PCT were the influencing factors of secondary necrotizing pneumonia in children with Streptococcus pneumoniae pneumonia (all P<0.05). The area under the curve of LECT2 was 0.636 for predicting secondary necrotizing pneumonia in children with Streptococcus pneumoniae pneumonia, and the area under the curve of the combined detection of all indicators was 0.988, which was of higher diagnostic value. Conclusions　The level of LECT2 is closely related to the occurrence of necrotizing pneumonia in children with Streptococcus pneumoniae pneumonia, and its increase may elevate the risk of developing necrotizing pneumonia. Therefore, LECT2 can serve as a potential biomarker for predicting the development of necrotizing pneumonia in children with Streptococcus pneumoniae pneumonia, aiding clinicians in taking more targeted treatment measures at an early stage to improve the prognosis of affected children.

Key words:

Streptococcus pneumoniae pneumonia, Necrotizing pneumonia, Leukocyte derived chemokine 2, Early diagnosis, Children

黄美子杨军张苗.

LECT2水平与肺炎链球菌肺炎患儿发生坏死性肺炎的关系及临床意义 [J]. 国际医药卫生导报, 2024, 30(20): 3393-3397.

Huang Meizi, Yang Jun, Zhang Miao.

Relationship between level of LECT2 and occurrence of necrotizing pneumonia in children with Streptococcus pneumoniae pneumonia and its clinical significance [J]. International Medicine and Health Guidance News, 2024, 30(20): 3393-3397.

参考文献

[1] 邓正兵,何磊,曹禺露,等. 痰涂片联合CRP、PCT及IL-6水平检测对老年细菌性肺炎的诊断价值研究[J]. 中国现代医学杂志,2023,33(14):70-75. DOI:10.3969/j.issn.1005- 8982.2023.14.012.
[2] 曲奎尧,张珊,谢春艳,等. 免疫胶体金法与间接免疫荧光法检测对下呼吸道感染患儿肺炎支原体感染的诊断价值分析[J]. 海军医学杂志,2023,44(3):270-274. DOI:10.3969/j.issn.1009-0754.2023.03.013.
[3] Zhu MH, Liu YJ, Li CY, et al. The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential[J]. Front Immunol, 2023, 14:1158083. DOI: 10.3389/fimmu.2023.1158083.
[4] 胡少博,张娜莉,程静梅. 血清KL-6水平与NSCLC患者PD-1相关免疫性肺炎的关联性[J]. 国际医药卫生导报,2024,30(4):602-605. DOI:10.3760/cma.j.issn.1007-1245. 2024.04.016.
[5] Chu TH, Ko CY, Tai PH, et al. Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma[J]. J Biol Chem, 2022, 298(10): 102442. DOI: 10.1016/j.jbc.2022.102442
[6] 中华人民共和国国家健康委员会,国家中医药局. 儿童社区获得性肺炎诊疗规范(2019年版)[J]. 中华临床感染病杂志,2019,12(1):6-13. DOI:10.3760/cma.j.issn.1674-2397. 2019.01.002.
[7] Shirasaki T, Yamagoe S, Shimakami T, et al. Leukocyte cell-derived chemotaxin 2 is an antiviral regulator acting through the proto-oncogene MET[J]. Nat Commun, 2022, 13(1): 3176. DOI: 10.1038/s41467-022-30879-3.
[8] 陈婷女,梁慕琼,梁亮.儿童重症肺炎支气管肺泡灌洗液病原学及疾病预后分析[J].广州医药,2022,53(3):53-56.DOI:10.3969/j.issn.1000-8535.2022.03.013.
[9] Zhu H, Lu Y, Xia J, et al. Aptamer-assisted protein orientation on silver magnetic nanoparticles: application to sensitive leukocyte cell-derived chemotaxin 2 surface plasmon resonance sensors[J]. Anal Chem, 2022, 94(4): 2109-2118. DOI: 10.1021/acs.analchem.1c04448.
[10] 褚明永,刘如喜,付理想,等. 24h血乳酸清除率联合NLR、PCT对重症监护病房重症肺炎28d病死风险的预测价值分析[J]. 中国现代医学杂志,2023,33(17):57-61. DOI:10.3969/j.issn.1005-8982.2023.17.010.
[11] 张楠,莫小兰,魏雪芹,等. 原发性肾病综合征患儿合并肺炎的病原学特点及抗感染药物分析[J]. 河北医科大学学报,2023,44(6):729-732. DOI:10.3969/j.issn.1007-3205. 2023.06.021.
[12] 滕双芩,匡竞. 耐碳青霉烯类肺炎克雷伯菌感染风险预测模型研究进展[J]. 河北医科大学学报,2023,44(8):978-982. DOI:10.3969/j.issn.1007-3205.2023.08.020.
[13] 余燕娟,李敏,靳秀红. 肺炎支原体坏死性肺炎患儿支气管肺泡灌洗液IL-17A及MUC5AC检测的临床意义[J]. 临床肺科杂志,2023,28(1):72-77. DOI:10.3969/j.issn.1009-6663. 2023.01.016.
[14] 梁银,田恬,赵红,等. 儿童病毒性肺炎血清肿瘤坏死因子超家族成员14、甲壳质酶蛋白40、可溶性白细胞介素2受体水平变化与短期预后的相关性[J]. 中国感染与化疗杂志,2023,23(5):574-579. DOI:10.16718/j.1009-7708.2023. 05.007.
[15] 李霞,环晶晶,许丹丹,等. 丙种球蛋白冲击治疗对老年重症社区获得性肺炎患者免疫系统功能、细胞因子及预后转归的影响[J]. 实用医院临床杂志,2023,20(1):16-19. DOI:10.3969/j.issn.1672-6170.2023.01.005.
[16] 黄全发. 我院耐青霉素肺炎链球菌患儿治疗研究[J]. 国际医药卫生导报,2002,18(7):73-74. DOI:10.3760/cma.j.issn.1007-1245.2002.07.037.
[17] 施姮,舒芳芳. 连翘苷调控细胞因子信号转导抑制因子1对肺炎链球菌诱导的肺泡上皮细胞凋亡和氧化应激的影响[J]. 中国临床药理学杂志,2023,39(8):1142-1146. DOI:10.13699/j.cnki.1001-6821.2023.08.017.
[18] 吴守业,林道炯,王亚洲. PCT/ALB联合CRP/ALB预测儿童肺炎链球菌感染致坏死性肺炎的临床价值[J]. 中国感染控制杂志,2023,22(4):398-403. DOI:10.12138/j.issn.1671- 9638.20233448.
[19] 廖婷,刘平. 小儿肺炎支原体合并肺炎链球菌性肺炎与单纯肺炎支原体体液免疫功能及CT表现比较[J]. 分子影像学杂志,2023,46(2):293-296. DOI:10.12122/j.issn.1674- 4500.2023.02.19.
[20] 郑宝英,牛志尚,周林,等. IL-17A基因多态性与儿童鼻咽部肺炎链球菌定植关系的研究[J]. 中国医刊,2023,58(9):981-985. DOI:10.3969/j.issn.1008-1070.2023.09.015.
[21] 董明星,韩宏武,王喜霞,等. 2022年1-12月咸阳市某儿童医院住院儿童肺炎链球菌感染的流行病学及临床特点[J]. 山东医药,2023,63(27):73-75. DOI:10.3969/j.issn.1002- 266X.2023.27.015.
[22] 黄光举,张慧玉,李娟,等. 肿瘤坏死因子相关激活蛋白、CD4+/CD8+、IL-4与儿童细菌性社区获得性肺炎经典炎症标志物的关系研究[J]. 蚌埠医学院学报,2022,47(4):482-486,490. DOI:10.13898/j.cnki.issn.1000-2200.2022. 04.014.